ASKA Pharmaceutical HoldingsLtd Future Growth
Future criteria checks 1/6
ASKA Pharmaceutical HoldingsLtd's earnings are forecast to decline at 0.5% per annum while its annual revenue is expected to grow at 4.5% per year. EPS is expected to decline by 0.5% per annum. Return on equity is forecast to be 8.7% in 3 years.
Key information
-0.5%
Earnings growth rate
-0.5%
EPS growth rate
Pharmaceuticals earnings growth | 12.6% |
Revenue growth rate | 4.5% |
Future return on equity | 8.7% |
Analyst coverage | Low |
Last updated | 17 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 71,492 | 6,282 | 4,647 | N/A | 2 |
3/31/2026 | 67,313 | 5,312 | 3,482 | N/A | 3 |
3/31/2025 | 64,651 | 4,894 | 4,600 | N/A | 3 |
3/31/2024 | 63,285 | 6,466 | 2,980 | N/A | 3 |
12/31/2023 | 62,026 | 6,513 | N/A | N/A | N/A |
9/30/2023 | 61,937 | 6,021 | 3,664 | 4,782 | N/A |
6/30/2023 | 61,215 | 4,343 | N/A | N/A | N/A |
3/31/2023 | 60,461 | 4,238 | 2,605 | 3,351 | N/A |
12/31/2022 | 59,687 | 4,391 | N/A | N/A | N/A |
9/30/2022 | 58,302 | 9,432 | 796 | 3,091 | N/A |
6/30/2022 | 57,655 | 4,515 | N/A | N/A | N/A |
3/31/2022 | 56,607 | 4,290 | 465 | 2,842 | N/A |
12/31/2021 | 56,010 | 4,344 | N/A | N/A | N/A |
9/30/2021 | 56,255 | -1,635 | 3,726 | 4,647 | N/A |
6/30/2021 | 55,688 | 3,072 | N/A | N/A | N/A |
3/31/2021 | 55,181 | 2,713 | 5,437 | 6,541 | N/A |
12/31/2020 | 54,685 | 2,036 | N/A | N/A | N/A |
9/30/2020 | 53,363 | 1,624 | 6,878 | 8,149 | N/A |
6/30/2020 | 52,265 | 825 | N/A | N/A | N/A |
3/31/2020 | 52,542 | 649 | -2,756 | -492 | N/A |
12/31/2019 | 50,897 | 592 | N/A | N/A | N/A |
9/30/2019 | 49,811 | 1,578 | -4,750 | -2,317 | N/A |
6/30/2019 | 47,936 | 1,245 | N/A | N/A | N/A |
3/31/2019 | 46,706 | 1,744 | -13,219 | 2,504 | N/A |
12/31/2018 | 47,247 | 1,578 | N/A | N/A | N/A |
9/30/2018 | 47,367 | 1,488 | -15,517 | 269 | N/A |
6/30/2018 | 48,892 | 2,407 | N/A | N/A | N/A |
3/31/2018 | 48,944 | 2,388 | -1,434 | 76 | N/A |
12/31/2017 | 49,765 | 2,060 | N/A | N/A | N/A |
9/30/2017 | 49,265 | 3,312 | N/A | 6,470 | N/A |
6/30/2017 | 49,353 | 3,461 | N/A | N/A | N/A |
3/31/2017 | 48,527 | 2,944 | N/A | 12,063 | N/A |
12/31/2016 | 47,158 | 3,531 | N/A | N/A | N/A |
9/30/2016 | 46,424 | 1,581 | N/A | 6,784 | N/A |
6/30/2016 | 44,479 | 1,040 | N/A | N/A | N/A |
3/31/2016 | 43,215 | 701 | N/A | -1,349 | N/A |
12/31/2015 | 42,721 | 792 | N/A | N/A | N/A |
9/30/2015 | 40,819 | 752 | N/A | 605 | N/A |
6/30/2015 | 43,197 | 1,085 | N/A | N/A | N/A |
3/31/2015 | 42,907 | 1,193 | N/A | 5,710 | N/A |
12/31/2014 | 42,335 | 695 | N/A | N/A | N/A |
9/30/2014 | 42,670 | 809 | N/A | 3,302 | N/A |
6/30/2014 | 39,393 | 282 | N/A | N/A | N/A |
3/31/2014 | 39,501 | 495 | N/A | 2,616 | N/A |
12/31/2013 | 40,632 | 1,000 | N/A | N/A | N/A |
9/30/2013 | 40,851 | 896 | N/A | 2,168 | N/A |
6/30/2013 | 41,198 | 1,211 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4886's earnings are forecast to decline over the next 3 years (-0.5% per year).
Earnings vs Market: 4886's earnings are forecast to decline over the next 3 years (-0.5% per year).
High Growth Earnings: 4886's earnings are forecast to decline over the next 3 years.
Revenue vs Market: 4886's revenue (4.5% per year) is forecast to grow faster than the JP market (4.4% per year).
High Growth Revenue: 4886's revenue (4.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4886's Return on Equity is forecast to be low in 3 years time (8.7%).